Safety and Efficacy Study of DCVax-Direct in Solid Tumors

Clinical trial NCT01882946 · UNKNOWN

Trial details

NCT number: NCT01882946
Sponsor: Northwest Biotherapeutics
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Tumor Metastatic Solid Tissue Tumors Liver Cancer Colorectal Cancer Pancreatic Cancer Melanoma

Start date: 2013-06-01
Primary completion: 2016-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.